Breaking News

Jubilant HollisterStier Wins Parenteral Contracts

November 14, 2012

Will manufacture sterile products at Spokane and Montreal sites

Jubilant HollisterStier’s Contract Manufacturing & Services division, a subsidiary of Jubilant Life Sciences, has recently secured more than $100 million in contracts with pharmaceutical companies for the commercial manufacture of multiple sterile parenteral products. These awards expand existing relationships and will be executed across both parenteral manufacturing locations in Spokane WA, and Montreal, Canada. The commercial technology transfer efforts are expected to begin in 2013.
 
“We are excited to expand our existing strategic commercial relationships, and will bring forward our capabilities in manufacturing excellence, rigorous quality oversight and project management to support a smooth and timely transfer to our manufacturing locations,” said Marcelo Morales, Jubilant HollisterStier’s chief executive officer.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks